QRISK 3 – Clare Hawley - Summary slide

Slides:



Advertisements
Similar presentations
Cardiovascular Risk Assessment
Advertisements

Summary Prepared by Melvyn Rubenfire, MD
By Apurva D. Shah, FACC Northside Heart and Vascular Institute.
Foos et al, EASD, Lisbon, 13 September 2011 Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta- analysis studies Volker.
Modelling the potential economic impact of investment in Public Health Professor Malcolm Whitfield Director of The Centre for Health & Social Care Research.

CHD Prevention and Risk Asssessment: Old concepts new context? Dr Paul D MacIntyre Director of Cardiology, RHH.
CVD risk estimation and prevention: An overview of SIGN 97.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Healthy Living Factors in Preventing Serious Disease ( Diabetes, Cancer Heart Attack, Stroke)
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Risk estimation and the prevention of cardiovascular disease SIGN 97.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Health Belief Model (HBM)
Antithrombotic Trialists’ (ATT) Collaboration. Lancet 2009;373:
How can you estimate simply the cardiovascular risk of your patients?
Supporting Vascular Risk Assessment: QDScore Julia Hippisley-Cox 15 th April 2010.
+ NHS Health Check Programme Priscilla Wong GPST2.
Understanding Health. What is health? An easy answer? Is it when you are not ill? Do people agree? What factors do you consider?
Cardiovascular Disease Middlesbrough Update for Middlesbrough Scrutiny Committee 4 th November 2014 Dr Tanja Braun.
Hippisley-Cox J, Coupland C. Heart 2010;96:
Chapter 1 Why Physical Fitness? CHAPTER OUTLINE Life Expectancy vs. Healthy Life Expectancy Lifestyle as a Health Problem Physical Activity and Exercise.
CARDIOVASCULAR FITNESS. WHAT IS IT?  Cardio = of or relating to the heart  Vascular = of or relating to blood vessels  Cardiovascular fitness = the.
Erectile Dysfunction and Cardiovascular Risk Dr Laura Backhouse Foundation Year 2 Gloucestershire Trust Prevent the 3 year progression from erectile dysfunction.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
HOW THE HEART WORKS BLOOD FLOW THROUGH THE HEART.
Non-communicable diseases (NCDs) include:
C Wilson, KM Rhodes, RA Payne
QScores: Supporting Vascular Risk Assesessment
Copyright © 2012 American Medical Association. All rights reserved.
Heart Disease in Indians
American Heart Month Resources:
Champlain LHIN Fall Prevention Initiative
Section 3: CKD, CVD and mortality
Pravastatin in Elderly Individuals at Risk of Vascular Disease
Non-communicable diseases (NCDs) include:
Improving Chronic Care Management
Heart Health & Diabetes
HWE 200Competitive Success/tutorialrank.com
HWE 200 Education for Service-- tutorialrank.com.
Statin Selection in the Elderly
Prevention Cardiovascular disease
Teaching Tool: Blood Pressure Classification
Recognizing Your Risk for Cardiovascular Disease
Cardiovascular Disease (CVD) in Texas
Tailoring Statin Therapy in Women
Updates on CVOT Data and Clinical Comparisons That Matter
AGES HEALTH Le Thi Kim Thoa MD, MPH Faculty of Public Health
Select Topics in Cardiovascular Medicine
Clinical Advances in Type 2 Diabetes and Cardiovascular Risk
Cardiovascular disease
The Hypertension in the Very Elderly Trial (HYVET)
Precision Management of RA and Comorbidities
US Preventive Services Task Force. Ann Intern Med 2009;150:
Type 2 diabetes.
Cardiovascular disease
Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197
Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study by James P Sheppard, Kate Fletcher, Richard J McManus,
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
Advances in Hypertriglyceridemia Treatment
Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.
Texas Framework For Heart Disease and Stroke Improved Quality of Life
Elevated Admission Plasma Glucose Following ACS
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Figure 1 Relationships between magnitude of antithrombotic benefit vs
An ethnographic account of the benefits and challenges of providing NHS Health Checks at community outreach events Background NHS Health Checks: Vascular.
Preventative Cardiology
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

QRISK 3 – Clare Hawley - Summary slide CVD is the leading cause of mortality & disability in the UK & is largely preventable The ability to estimate a person’s CV risk, based on their modifiable & non modifiable risk factors, is helpful in communicating this risk and informing the need for lifestyle change & primary prevention In people without existing CVD, QRISK3 score can: Predict the likelihood of a CV event over the next 10-years Calculate the heart age, giving an idea of lifetime risk which can be more meaningful to younger people and might avoid over treatment in otherwise fit and healthy elderly people Inform the benefit of risk factor modification In people without existing CVD the QResearch cardiovascular disease risk algorithm (QRISK) score, can be used to assess the likelihood of stroke or heart attack over the next 10-years, heart age, effect of risk factor modification